Total Voting Rights

RNS Number : 5941Q

Oncimmune Holdings PLC

01 March 2021

 

1 March 2021

Oncimmune Holdings plc

("Oncimmune" or the "Company")

Total Voting Rights

In accordance with the Disclosure Guidance and Transparency Rules (DTR 5.6), Oncimmune makes the following disclosure with respect to the share capital and voting rights of the Company.

Pursuant to the Company's existing block admission announced on 15 September 2020, and following the exercise of options over 47,647 ordinary shares in aggregate during February 2021 by current and former employees, as at 28 February 2021, the Company's issued share capital was 63,710,093 ordinary shares of £0.01 each with voting rights. The Company does not hold any shares in treasury.

The above figure of 63,710,093 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Oncimmune Holdings plc

Ron Kirschner, Company Secretary

[e-mail]

Zeus Capital Limited (Nominated Adviser and Joint Broker)

Andrew Jones, Daniel Harris, Victoria Ayton

[phone]

N+1 Singer (Joint Broker)

Aubrey Powell, Harry Gooden, Iqra Amin, James Fischer

[phone]

WG Partners (Joint Broker)

David Wilson, Chris Lee

[phone]

Media enquiries:

FTI Consulting

Ben Atwell, Michael Trace, Alex Davis

[e-mail]

[phone]

 

END

 

 

TVREANAKAALFEFA